Treatment of neurobrucellosis: what is known and what remains to be answered

References

• Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect. Dis.6(2), 91–99 (2006).
   PubMed Web of Science ®Google Scholar
• Corbel MJ. Brucellosis: an overview. Emerg. Infect. Dis.3(2), 213–221 (1997).
   PubMed Web of Science ®Google Scholar
• Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N. Engl. J. Med.352(22), 2325–2336 (2005).
   PubMed Web of Science ®Google Scholar
• Young EJ. An overview of human brucellosis. Clin. Infect. Dis.21(2), 283–289 (1995).
   PubMed Web of Science ®Google Scholar
• Colmenero JD, Reguera JM, Martos F et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore)75(4), 195–211 (1996).
   PubMed Web of Science ®Google Scholar
• Pappas G, Akritidis N, Tsianos E. Effective treatments in the management of brucellosis. Expert Opin. Pharmacother.6(2), 201–209 (2005).
   PubMed Web of Science ®Google Scholar
• Memish ZA, Balkhy HH. Brucellosis and international travel. J. Travel Med.11(1), 49–55 (2004).
   PubMed Web of Science ®Google Scholar
• Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell. Mol. Life Sci.63(19–20), 2229–2236 (2006).
   PubMed Web of Science ®Google Scholar
• McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin. Infect. Dis.15(4), 582–590 (1992).
   PubMed Web of Science ®Google Scholar
• Spink WW. The Nature of Brucellosis. University of Minnesota Press, MN, USA 146–190 (1956).
   Google Scholar
• Fincham RW, Sahs AL, Joynt RJ. Protean manifestations of nervous system brucellosis. Case histories of a wide variety of clinical forms. JAMA184, 269–275 (1963).
   PubMed Web of Science ®Google Scholar
• Shakir RA, Al-Din AS, Araj GF, Lulu AR, Mousa AR, Saadah MA. Clinical categories of neurobrucellosis. A report on 19 cases. Brain110(Pt 1), 213–223 (1987).
   PubMed Web of Science ®Google Scholar
• Gorvel JP, Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet. Microbiol.90(1–4), 281–297 (2002).
   PubMed Web of Science ®Google Scholar
• Akova M, Gur D, Livermore DM, Kocagoz T, Akalin HE. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob. Agents Chemother.43(5), 1298–1300 (1999).
   PubMed Web of Science ®Google Scholar
• Navarro E, Segura JC, Castano MJ, Solera J. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin. Infect. Dis.42(9), 1266–1273 (2006).
   PubMed Web of Science ®Google Scholar
• Boura P, Skendros P, Kountouras J, Zacharioudaki E, Tsapas T. Effect of bacterial extracts on the immunologic profile in chronic relapsing brucellosis patients. Int. J. Immunopathol. Pharmacol.12(2), 103–111 (1999).
   PubMed Web of Science ®Google Scholar
• Billard E, Cazevieille C, Dornand J, Gross A. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect. Immun.73(12), 8418–8424 (2005).
   PubMed Web of Science ®Google Scholar
• Pappas G, Solera J, Akritidis N, Tsianos E. New approaches to the antibiotic treatment of brucellosis. Int. J. Antimicrob. Agents26, 101–105 (2005)
   PubMed Web of Science ®Google Scholar
• Sande MA. Antibiotic therapy of bacterial meningitis: lessons we’ve learned. Am. J. Med.71(4), 507–510 (1981).
   PubMed Web of Science ®Google Scholar
• Palenque E, Otero JR, Noriega AR. In vitro susceptibility of Brucella melitensis to new cephalosporins crossing the blood–brain barrier. Antimicrob. Agents Chemother.29(1), 182–183 (1986).
   PubMed Web of Science ®Google Scholar
• Bosch J, Linares J, Lopez de Goicoechea MJ, Ariza J, Cisnal MC, Martin R. In vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. J. Antimicrob. Chemother.17(4), 459–461 (1986).
   PubMed Web of Science ®Google Scholar
• Bodur H, Balaban N, Aksaray S et al. Biotypes and antimicrobial susceptibilities of Brucella isolates. Scand. J. Infect. Dis.35(5), 337–338 (2003).
   PubMed Web of Science ®Google Scholar
• Baykam N, Esener H, Ergonul O, Eren S, Celikbas AK, Dokuzoguz B. In vitro antimicrobial susceptibility of Brucella species. Int. J. Antimicrob. Agents23(4), 405–407 (2004).
   PubMed Web of Science ®Google Scholar
• Tanyel E, Coban AY, Koruk ST et al. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region. Saudi Med. J.28(8), 1239–1242 (2007).
   PubMed Web of Science ®Google Scholar
• al-Idrissi HY, Uwaydah AK, Danso KT, Qutub H, al-Mousa MS. Ceftriaxone in the treatment of acute and subacute human brucellosis. J. Int. Med. Res.17(4), 363–368 (1989).
   PubMed Web of Science ®Google Scholar
• Lang R, Dagan R, Potasman I, Einhorn M, Raz R. Failure of ceftriaxone in the treatment of acute brucellosis. Clin. Infect. Dis.14(2), 506–509 (1992).
   PubMed Web of Science ®Google Scholar
• Young EJ. Human brucellosis. Rev. Infect. Dis.5(5), 821–842 (1983).
   PubMedGoogle Scholar
• Pappas G, Seitaridis S, Akritidis N, Tsianos E. Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen. Int. J. Antimicrob. Agents24(5), 502–507 (2004).
   PubMed Web of Science ®Google Scholar
• Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobrucellosis: clinical and neuroimaging correlation. Am. J. Neuroradiol.25(3), 395–401 (2004).
   PubMed Web of Science ®Google Scholar
• Adeva-Bartolome MT, Montes-Martinez I, Castellanos-Pinedo F, Zurdo-Hernandez JM, de Castro-Garcia FJ. Neurobrucellosis: four case reports. Rev. Neurol.41(11), 664–666 (2005).
   PubMed Web of Science ®Google Scholar
• Solera J, Geijo P, Largo J et al. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis. Clin. Infect. Dis.39(12), 1776–1782 (2004).
   PubMed Web of Science ®Google Scholar
• Solera J, Lozano E, Martinez-Alfaro E et al. Brucellar spondylitis: review of 35 cases and literature survey. Clin. Infect. Dis.29(6), 1440–1449 (1999).
   PubMed Web of Science ®Google Scholar
• Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect. Dis.7(3), 191–200 (2007).
   PubMed Web of Science ®Google Scholar
• Samdani PG, Patil S. Neurobrucellosis. Indian Pediatr.40(6), 565–568 (2003).
   PubMedGoogle Scholar
• Davis CE, Troy SB, Tonna I et al. Brucellosis – correspondence. N. Engl. J. Med.353(10), 1071–1072 (2005).
   PubMed Web of Science ®Google Scholar
• Ayala-Gaytan JJ, Ortegon-Baqueiro H, de la Maza M. Brucella melitensis cerebellar abscess. J. Infect. Dis.160(4), 730–732 (1989).
   PubMed Web of Science ®Google Scholar
• Colmenero JD, Queipo-Ortuno MI, Reguera JM, Baeza G, Salazar JA, Morata P. Real time polymerase chain reaction: a new powerful tool for the diagnosis of neurobrucellosis. J. Neurol. Neurosurg. Psychiatry76(7), 1025–1027 (2005).
   PubMed Web of Science ®Google Scholar
• Morata P, Queipo-Ortuno MI, Reguera JM, Garcia-Ordonez MA, Pichardo C, Colmenero JD. Posttreatment follow-up of brucellosis by PCR assay. J. Clin. Microbiol.37(12), 4163–4166 (1999).
   PubMed Web of Science ®Google Scholar
• Guerreiro CA, Scaff M, Callegaro D, Facure NO, Dianin VM. Neurobrucellosis: report of 3 cases. Arq. Neuropsiquiatr.39(2), 203–213 (1981).
   PubMedGoogle Scholar
• Bashir R, Al-Kawi MZ, Harder EJ, Jinkins J. Nervous system brucellosis: diagnosis and treatment. Neurology35(11), 1576–1581 (1985).
   PubMed Web of Science ®Google Scholar
• Bouza E, Garcia de la Torre M, Parras F, Guerrero A, Rodriguez-Creixems M, Gobernado J. Brucellar meningitis. Rev. Infect. Dis.9(4), 810–822 (1987).
   PubMedGoogle Scholar
• al Deeb SM, Yaqub BA, Sharif HS, Phadke JG. Neurobrucellosis: clinical characteristics, diagnosis, and outcome. Neurology39(4), 498–501 (1989).
   PubMed Web of Science ®Google Scholar
• Lubani MM, Dudin KI, Araj GF, Manandhar DS, Rashid FY. Neurobrucellosis in children. Pediatr. Infect. Dis. J.8(2), 79–82 (1989).
   PubMed Web of Science ®Google Scholar
• Sanchez-Sousa A, Torres C, Campello MG et al. Serological diagnosis of neurobrucellosis. J. Clin. Pathol.43(1), 79–81 (1990).
   PubMed Web of Science ®Google Scholar
• al-Eissa YA. Clinical and therapeutic features of childhood neurobrucellosis. Scand. J. Infect. Dis.27(4), 339–343 (1995).
   PubMed Web of Science ®Google Scholar
• Estevao MH, Barosa LM, Matos LM, Barroso AA, da Mota HC. Neurobrucellosis in children. Eur. J. Pediatr.154(2), 120–122 (1995).
   PubMed Web of Science ®Google Scholar
• Marzo Sola ME, Calderon Giron C, Ayuso Blanco T, Uson Martin M, Marta Moreno ME, Bestue Cardiel M. Neurobrucellosis. A report of 13 cases. Neurologia10(9), 375–379 (1995).
   PubMedGoogle Scholar
• Omar FZ, Zuberi S, Minns RA. Neurobrucellosis in childhood: six new cases and a review of the literature. Dev. Med. Child. Neurol.39(11), 762–765 (1997).
   PubMed Web of Science ®Google Scholar
• Bellissima P, Turturici MA. Neurobrucellosis: clinical and therapeutic features. Infez. Med.6(1), 25–30 (1998).
   PubMedGoogle Scholar
• Akdeniz H, Irmak H, Anlar O, Demiroz AP. Central nervous system brucellosis: presentation, diagnosis and treatment. J. Infect.36(3), 297–301 (1998).
   PubMed Web of Science ®Google Scholar
• Kochar DK, Kumawat BL, Agarwal N et al. Meningoencephalitis in brucellosis. Neurol. India48(2), 170–173 (2000).
   PubMed Web of Science ®Google Scholar
• Aygen B, Doganay M, Sumerkan B, Yildiz O, Kayabas U. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med. Malad. Infect.32(2002), 485–493 (2002).
   Web of Science ®Google Scholar
• Bodur H, Erbay A, Akinci E, Colpan A, Cevik MA, Balaban N. Neurobrucellosis in an endemic area of brucellosis. Scand. J. Infect. Dis.35(2), 94–97 (2003).
   PubMed Web of Science ®Google Scholar
• Eren S, Bayam G, Ergonul O et al. Cognitive and emotional changes in neurobrucellosis. J. Infect.53(3), 184–189 (2006).
   PubMed Web of Science ®Google Scholar
• Mantur BG, Biradar MS, Bidri RC et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years’ experience in an endemic area. J. Med. Microbiol.55(Pt 7), 897–903 (2006).
   PubMed Web of Science ®Google Scholar